Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3728177> ?p ?o }
Showing triples 1 to 47 of
47
with 100 triples per page.
- Q3728177 subject Q6442932.
- Q3728177 subject Q7335370.
- Q3728177 subject Q8503308.
- Q3728177 subject Q8919936.
- Q3728177 abstract "Carbinoxamine (Clistin, Palgic, Rondec, Rhinopront) is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatographism and allergic conjunctivitis. Carbinoxamine is a histamine antagonist, specifically an H1-antagonist. The maleic acid acid salt of the levorotatory isomer is sold as the prescription drug rotoxamine.Carbinoxamine is available in various countries around the world by itself, combined with decongestants such as pseudoephedrine, and also with other ingredients including paracetamol, aspirin, and codeine.In June 2006 the FDA announced that more than 120 branded pharmacy products containing carbinoxamine were being illegally marketed and demanded they be removed from the marketplace. This action was precipitated by twenty-one reported deaths in children under the age of two who had been administered carbinoxamine-containing products. Despite the fact that the drug had not been studied in this age group, a multitude of OTC preparations containing carbinoxamine were being marketed for infants and toddlers. At present, all carbinoxamine-containing formulations are approved only for adults or children ages 3 or older.Carbinoxamine is used in the treatment of severe itching in patients with CD5.".
- Q3728177 atcPrefix "R06".
- Q3728177 atcSuffix "AA08".
- Q3728177 casNumber "486-16-8".
- Q3728177 chEBI "3398".
- Q3728177 drugbank "DB00748".
- Q3728177 fdaUniiCode "VED9E376NC".
- Q3728177 iupacName "2-[(4-Chlorophenyl)-pyridin-2-yl-methoxy]-N,N-".
- Q3728177 iupacName "dimethyl-ethanamine".
- Q3728177 pubchem "2564".
- Q3728177 thumbnail Carbinoxamine.svg?width=300.
- Q3728177 wikiPageWikiLink Q113259.
- Q3728177 wikiPageWikiLink Q1175580.
- Q3728177 wikiPageWikiLink Q187440.
- Q3728177 wikiPageWikiLink Q204711.
- Q3728177 wikiPageWikiLink Q272436.
- Q3728177 wikiPageWikiLink Q2937681.
- Q3728177 wikiPageWikiLink Q324089.
- Q3728177 wikiPageWikiLink Q418145.
- Q3728177 wikiPageWikiLink Q5037865.
- Q3728177 wikiPageWikiLink Q6442932.
- Q3728177 wikiPageWikiLink Q6802523.
- Q3728177 wikiPageWikiLink Q7335370.
- Q3728177 wikiPageWikiLink Q7812962.
- Q3728177 wikiPageWikiLink Q8503308.
- Q3728177 wikiPageWikiLink Q8919936.
- Q3728177 atcPrefix "R06".
- Q3728177 atcSuffix "AA08".
- Q3728177 casNumber "486".
- Q3728177 chebi "3398".
- Q3728177 drugbank "DB00748".
- Q3728177 iupacName "2".
- Q3728177 iupacName "dimethyl-ethanamine".
- Q3728177 pubchem "2564".
- Q3728177 unii "VED9E376NC".
- Q3728177 type ChemicalSubstance.
- Q3728177 type Drug.
- Q3728177 type ChemicalObject.
- Q3728177 type Thing.
- Q3728177 type Q8386.
- Q3728177 comment "Carbinoxamine (Clistin, Palgic, Rondec, Rhinopront) is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a.".
- Q3728177 label "Carbinoxamine".
- Q3728177 depiction Carbinoxamine.svg.